A simple method for producing a clinically applicableradiopharmaceutical composition containing1-(2,2-dihydroxymethyl-3- [18F]fluoropropyl)-2-nitroimidazole([18F]DiFA) or a salt thereof as an active ingredient, isprovided which includes a synthesis step of obtaining acrude product of [18F]DiFA from a labeling precursorcompound for [18F]DiFA; and a purification step ofpurifying the crude product, in which the purification stepincludes purifying [18F]DiFA using two or more differenttypes of reverse phase solid phase extraction cartridges.